Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model

Cancer Research

Volumn 62, Issue 11, 2002, Pages 3276-3281

  Rounbehler, Robert J ^a   Rogers, Pamela M ^a   Conti, Claudio J ^a   Johnson, David G ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KERATIN; KERATIN 5; MYC PROTEIN; TRANSCRIPTION FACTOR E2F; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM; GENE ACTIVITY; GENE FUNCTION; GENE INACTIVATION; MOUSE; NONHUMAN; NULL ALLELE; ONCOGENE MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; TISSUE SPECIFICITY; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; GENE SILENCING; GENES, MYC; GENES, TUMOR SUPPRESSOR; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS C-MYC; SKIN NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036606643     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Toward an understanding of the functional complexity of the E2F and retinoblastoma families
2. The regulation of E2F by pRB-family proteins
3. The Rb/E2F pathway: Expanding roles and emerging paradigms
4. Expression of transcription factor E2F1 induces quiescent cells to enter S phase
5. Distinct roles for E2F proteins in cell growth control and apoptosis
6. p53 and E2F-1 cooperate to mediate apoptosis
7. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors
8. Mutation of E2f-1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos
9. Role for the p53 homologue p73 in E2F-1-induced apoptosis
10. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation
11. E2F-1 potentiates cell death by blocking antiapoptotic signaling pathways
12. ARF links the tumour suppressors RB and p53
13. ARF differentially modulates apoptosis induced by E2F1 and Myc
14. Increased E 2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53
15. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model
16. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis
17. Tumor induction and tissue atrophy in mice lacking E2F-1
18. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rbl(+/-) mice
19. The paradox of E2F1: Oncogene and tumor suppressor gene
20. c-Myc target genes involved in cell growth, apoptosis, and metabolism
21. Functional role for c-myc in mitogenic response to platelet-derived growth factor
22. Microinjected c-myc as a competence factor
23. Mediation of c-Myc-induced apoptosis by p53
24. c-Myc induces apoptosis in epithelial cells by both p53-dependent and p53-independent mechanisms
25. Differential activities of E2F family members suggest unique functions in regulating transcription
26. EIA-dependent trans-activation of the human MYC promoter is mediated by the E2F factor
27. Nuclear factor E2F mediates basic transcription and trans-activation by Ela of the human MYC promoter
28. E2F-dependent regulation of human MYC: Trans-activation by cyclins DI and A overrides tumour suppressor protein functions
29. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and GI/S-regulatory genes
30. Regulation of BRCAI expression by the Rb-E 2F pathway
31. Complex transcriptional regulatory mechanisms control expression of the E2F3 locus
32. Myc and Ras collaborate in inducing accumulation of active cyclin E/CDK2 and E2F
33. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals
34. Myc lacks E2F1's ability to suppress skin carcinogenesis
35. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
36. The mouse skin as a model for chemical carcinogenesis
37. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis
38. Myc requires distinct E 2F activities to induce S phase and apoptosis
39. Oncogenic capacity of the E2F1 gene
40. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation
41. Multiple members of the E2F transcription factor family are the products of oncogenes
42. Effects of an Rb mutation in the mouse
43. No effect of loss of E2FI on liver regeneration or hepatocarcinogenesis in C57BL/6J or C3H/HeJ mice